Jinghe Li

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Imeglimin ameliorates MASLD by targeting PEN2 to activate AMPK pathway.

Imeglimin ameliorates MASLD by targeting PEN2 to activate AMPK pathway.

Journal: Metabolism: clinical and experimental

Published: July 29, 2025

Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.

Metabolic reprogramming directed by super-enhancers in tumors: An emerging landscape.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 30, 2023

Emerging roles of ferroptosis-related miRNAs in tumor metastasis.

Emerging roles of ferroptosis-related miRNAs in tumor metastasis.

Journal: Cell death discovery

Published: March 12, 2023

Emerging role of ferroptosis-related circular RNA in tumor metastasis.

Emerging role of ferroptosis-related circular RNA in tumor metastasis.

Journal: Frontiers in pharmacology

Published: February 17, 2023

Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.

Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.

Journal: Theranostics

Published: September 21, 2016

SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer.

SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer.

Journal: Cancer investigation

Published: July 09, 2016

The clinicopathological significance of Jagged1 and DLL4 in gallbladder cancer.

The clinicopathological significance of Jagged1 and DLL4 in gallbladder cancer.

Journal: Tumori

Published: March 14, 2016

[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.

[Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.

Journal: International journal of oncology

Published: January 28, 2016

CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.

CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.

Journal: International journal of oncology

Published: January 28, 2016

Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.

Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.

Journal: International journal of oncology

Published: December 03, 2015

MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.

MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.

Journal: Molecular medicine reports

Published: September 23, 2015

The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.

The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.

Journal: Pathology oncology research : POR

Published: March 12, 2015

Showing 1-12 of 27

Last Updated: 09/26/2026